Relevance of ploidy related parameters for prognosis in malignant fibrous histiocytomas

Anticancer Research

Volumn 19, Issue 6 B, 1999, Pages 5211-5216

  Brinck, Ulrich ^a,d   Korabiowska, Monika ^a   Buschmann, Nadine ^a   Stachura, Jerzy ^b   Ruschenburg, Ilka ^a   Cordon Cardo, Carlos ^c   Schauer, Alfred ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d Department of Gastroenteropathology ^*  (Germany)

Author keywords

CAS200; MFH; Ploidy

Indexed keywords

DNA;

ADOLESCENT; ADULT; AGED; ANEUPLOIDY; ANIMAL CELL; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CHILD; DIPLOIDY; DNA DETERMINATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE CYTOMETRY; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MULTIVARIATE ANALYSIS; NONHUMAN; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; RAT; REGRESSION ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DNA, NEOPLASM; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLOIDIES; PROGNOSIS;

EID: 0033367226     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Weiss SW, Enzinger FM: Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer 41: 2250-2266, 1978.
2. Doussal VL, Coindre JM, Leroux A, Hacene K, Terrier P, Bui NB, Bonichon F, Collin F, Mandard AM, Contesso G: Prognostic factors for patients with localized primary malignant fibrous histiocytoma. A multicenter study of 216 patients with multivariate analysis. Cancer 77: 1823-1830, 1996.
3. Brinck U, Cordon-Cardo C, Korabiowska M, Trybus Galuszka H, Stachura J, Parwaresch MR, Schauer A: Prognostic relevance of histologic grading, the cell cycle-associated antigen Ki-S1 and cell cycle regulators in malignant fibrous histiocytomas: a multivariate analysis. Verh Dtsch Ges Path 82: 232-238, 1998.
4. Bosari S, Lee AKC, Wiley BD, Heatley GJ, Silverman ML: Flow cytometric and image analyses of colorectal adenocarcinomas: a comparative study with clinical correlations. Am J Clin Pathol 99: 187-194, 1993.
5. Danque POV, Chen HB, Patil J, Jagirdar J, Orsatti G, Paronetto F: Image analysis versus flow cytometry for DNA ploidy quantitation of solid tumors: a comparison of six methods of sample preparations. Mod Pathol 6: 270-275, 1993.
6. Itakura Y, Sasano H, Mori S, Nagura H: DNA ploidy in human esophageal squamous dysplasias and squamous cell carcinomas as determined by image analysis. Mod Pathol 7: 867-873, 1994.
7. Padberg BC, Arps H, Franke U: DNA cytophotometry and prognosis in ovarian tumors of borderline malignancy: A clinicomorphologic study of 80 cases. Cancer 69: 2510-2514, 1992,
8. Cohen C: Image cytometric analysis in pathology. Hum Pathol 27: 482-493, 1996.
9. Alvegard TA, Berg NO, Baldetorp B: Cellular DNA content and prognosis of high grade soft tissue sarcoma: the Scandinavian Sarcoma Group Experience. J Clin Pathol 8: 538-547, 1990.
10. Bauer HC, Kreicbergs A, Tribukait B: DNA content prognostic in soft tissue sarcoma: 102 patients followed for 1-10 years. Acta Orthop Scand 62: 187-194, 1991.
11. Michie BA, Black C, Reid RP, Barret A, Hamblen DL: Image analysis derived ploidy and proliferation indices in soft tissue sarcomas: Comparison with clinical outcome. J Clin Pathol 47: 443-447, 1994.
12. Gustafson P, Rydholm A, Willen H, Baldetorp B, Ferno M, Akerman M: Liposarcoma, a population-based epidemiologic and prognostic study of features 43 patients, including tumor DNA content. Int J Cancer 55: 541-546, 1993.
13. Gustafson P, Willen H, Baldetorp B, Ferno M, Akerman M, Rydholm A: soft tissue leiomyosarcoma: a population-based epidemiologic and prognostic study of 48 patients, including DNA content. Cancer 70: 114-119, 1991.
14. Collin F, Chassevent A, Bonichon F, Bertrand G, terrier P, Coidre JM: Flow cytometric DNA content analysis of 185 soft tissue neoplasms indicates that S-phase fraction is a prognostic factor for sarcomas. Cancer 79: 2371-2379, 1997.
15. Plaat BEC, Muntinghe FLH, Molenaar WM, Hoekstra HJ, Bosveld HEP, Dam A, Dijkhuizen T, van den Berg E: Clinical outcome of patients with previously untreated soft tissue sarcomas in relation to tumor grade, DNA ploidy and katyotype. Int J Cancer 74: 396-402, 1997.
16. Brinck U, Korabiowska M, Knapik J, Ruschenburg I, Bartkowski SB, Stachura J: Comparison of the DNA content in recurrent and nonrecurrent basaliomas of the face. Pol J Pathol 49: 97-100, 1998.
17. Korabiowska M, Brinckmann U, Kellner S, Brinck U, Stachura J, Schauer A: Differences of ploidy status in progression of head and neck melanomas. Int J Oncol 10: 381-385, 1997.
18. Böcking A, Adler CP, Common HH; Hilgart M; Granzen B, Aufferemann B: Algorithm for a DNA-cytophotometric diagnosis and grading of malignancy. Analyt Quant Cytol 6: 1-8, 1984.
19. Böcking A: DNA cytometric diagnosis of prospective malignancy in borderline lesions of uterine cervix. Rec Results Cancer Res 122: 106-115, 1991.
20. Hedley DW, Friedlander ML, Taylor JW, Rugg CA, Musgrove EA: Method for analysis of cellular DNA content of paraffin embedded pathological material using flow cytometry. J Histoch Cytochem 31: 1333-1335, 1983.
21. Holm S: A simple sequentially rejective multiple test procedure. Scand J Statist 6: 65-70, 1979.
22. Kalbfleisch JD, Prentice RL: The statistical analysis of failure time data. 1st ed. New York: John Willey and Sons 1980.
23. Kreicbergs A, Tribukait B, Willems J: DNA flow analysis of soft tissue tumors. Cancer 59: 128-133, 1987.
24. Kroese MCS, Rutgers DH, Wils IS: The relevance of DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors. Cancer 65: 1782-1788, 1990.
25. Enzinger FM, Weiss SW: Soft tissue tumors. 3rd ed. Mosby St Louis, 1995.
26. Brinck U, Stachura J, Kellner S, Schauer A: Prognostic relevance of Ki-67 antigen and c-myc oncoprotein in malignant fibrous histiocytoma. Anticancer Res 15: 1915-1920, 1995.
27. Brinck U, Stachura J, Rudzki Z, Kellner S, Hoefer K, Schauer A; P-53 positivity and high proliferative index- factors of bad prognosis in malignant fibrous histiocytomas. In Vivo 9: 475-478, 1995.
28. Akerman M, Killander D, Rydholm A: Aspiration of musculoskeletal tumors for cytodiagnosis and DNA analysis. Acta Orthop Scand 55: 523-528, 1987.
29. Mellin W, Niezabitowski A, Brockman M, Ritter J, Wuisman P, Krieg V: DNA ploidy in soft tissue tumors: an evaluation of the prognostic implications in the different tumor types. In: Harms D, Schmidt D (eds), Soft Tissue Tumors. Berlin, Springer, 1995 pp95-122.
30. Tribukait B, Rönström M, Eposti PL: Quantitative and qualitative aspects of flow DNA measurements related to the cytologic grade in prostate carcinoma. Anal Quant Cytol 5: 107-111, 1983.
31. Hemmer J, Kreidler J: Flow cytometric DNA ploidy analysis of squamous cell carcinoma of the oral cavity. Comparison with histological staging and histologic grading. Cancer 66: 317-320, 1990.
32. Muhonen T, Pyrhonen S, Laasonen A, Wasenius VM, Asko-Seljavaara S, Franssila K, Kangas L: Tumour growth rate and DNA flow cytometry as prognostic factots in metastatic melanomas. Br J Cancer 66: 528-532, 1992.
33. Schmidt B, Weiberg S, Hollister K, Barnhill RL: Analysis of melanocytic lesions by DNA image cytometry. Cancer 73: 2972-2977, 1994.
34. Huuhtanen RL, Blomqvist CP, Wiklund TA, Virolainen MJ, Inkeri Elomaa A, Yi Pan: S-phase fraction of 155 soft tissue sarcomas: correlation with clinical outcome. Cancer 77: 1815-1822, 1996.